Biophytis Settles €2M Convertible Bond
| Field | Detail |
|---|---|
| Company | Biophytis SA |
| Form Type | 6-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financing, convertible-bond, settlement
TL;DR
Biophytis just settled a €2M convertible bond, watch for dilution.
AI Summary
On March 28, 2025, Biophytis S.A. announced the settlement and delivery of its €2 million convertible bond. This action is part of the company's ongoing financing activities.
Why It Matters
The settlement of this convertible bond impacts Biophytis's capital structure and potentially dilutes existing shareholders if converted.
Risk Assessment
Risk Level: medium — Settlement of convertible bonds can lead to share dilution, impacting existing shareholders.
Key Numbers
- €2 million — Convertible Bond Settlement (Amount settled on March 28, 2025)
Key Players & Entities
- Biophytis S.A. (company) — Registrant
- Stanislas Veillet (person) — Contact Person
- €2 million (dollar_amount) — Convertible bond principal
FAQ
What is the specific maturity date of the convertible bond?
The filing does not specify the maturity date of the convertible bond.
What is the conversion price or ratio for this convertible bond?
The filing does not provide details on the conversion price or ratio.
Who is the holder of this convertible bond?
The filing does not disclose the identity of the convertible bond holder.
What is the purpose of this convertible bond settlement?
The filing states it is part of the company's financing activities but does not elaborate on the specific purpose.
Are there any other outstanding convertible bonds?
This filing only pertains to the settlement of a specific €2 million convertible bond and does not provide information on other outstanding bonds.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 31, 2025 by Stanislas Veillet regarding Biophytis SA.